NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2
Open Access
- 14 March 2019
- journal article
- letter
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 104 (10), e455-e459
- https://doi.org/10.3324/haematol.2018.206961
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemiaNature Communications, 2016
- The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemiasNature Genetics, 2015
- DNA methylation-based subtype prediction for pediatric acute lymphoblastic leukemiaClinical Epigenetics, 2015
- Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALLBlood, 2013
- Pathogenesis of NUT Midline CarcinomaAnnual review of pathology, 2012
- Bmi1 reprograms CML B-lymphoid progenitors to become B-ALL–initiating cellsBlood, 2012
- Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domainsThe EMBO Journal, 2010
- Gene expression profiling–based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infantsBlood, 2010
- A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification studyThe Lancet Oncology, 2009
- Long-term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1Blood, 2008